Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

How Cells Respond Differently to a Cancer-Causing Gene

September 29, 2026
Continue Reading
how-cells-respond-differently-to-a-cancer-causing-gene
Posted inGenetics

Current Challenges in CAR T Manufacturing

September 29, 2026
Continue Reading
current-challenges-in-car-t-manufacturing
Posted inBiotechnology

Enanta sheds staffers as key antiviral, immunology readouts loom

September 29, 2026
Continue Reading
enanta-sheds-staffers-as-key-antiviral,-immunology-readouts-loom
Posted inBiotechnology

uniQure stock crashes as Huntington’s gene therapy data weaken

September 29, 2026
Continue Reading
uniqure-stock-crashes-as-huntington’s-gene-therapy-data-weaken
Posted inBiotechnology

Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui

September 29, 2026
Continue Reading
novo-agrees-$2.6b-deal-for-preclinical-glp-1/gip-drug-from-in-demand-hengrui
Posted inBiotechnology

AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos

September 29, 2026
Continue Reading
astrazeneca-scales-summit’s-pd-1xvegf-strategy-with-$2b-investment-to-fuel-adc-combos
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

how-cells-respond-differently-to-a-cancer-causing-gene
Posted inGenetics

How Cells Respond Differently to a Cancer-Causing Gene

September 29, 2026
Scientists at NYU Abu Dhabi say they have discovered that a single cancer-causing gene can trigger different responses in cells,…
Read More
current-challenges-in-car-t-manufacturing
Posted inGenetics

Current Challenges in CAR T Manufacturing

September 29, 2026
CAR T therapy has undergone a remarkable transformation over the past decade, evolving from an experimental treatment into a clinically…
Read More
enanta-sheds-staffers-as-key-antiviral,-immunology-readouts-loom
Posted inBiotechnology

Enanta sheds staffers as key antiviral, immunology readouts loom

September 29, 2026
As antiviral specialist Enanta Pharmaceuticals endeavors to expand into immunology, the company has decided to lay off 37 employees, Fierce…
Read More
uniqure-stock-crashes-as-huntington’s-gene-therapy-data-weaken
Posted inBiotechnology

uniQure stock crashes as Huntington’s gene therapy data weaken

September 29, 2026
uniQure’s Huntington’s disease gene therapy has failed to significantly slow disease progression after 48 months, sending the biotech’s stock down 41%…
Read More
novo-agrees-$2.6b-deal-for-preclinical-glp-1/gip-drug-from-in-demand-hengrui
Posted inBiotechnology

Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui

September 29, 2026
Novo’s ongoing attempts to rejuvenate its pipeline have seen the Big Pharma turn to one of the most in-demand drug…
Read More
astrazeneca-scales-summit’s-pd-1xvegf-strategy-with-$2b-investment-to-fuel-adc-combos
Posted inBiotechnology

AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos

September 29, 2026
AstraZeneca is investing $2 billion in Summit Therapeutics to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with antibody-drug conjugates…
Read More
ai-tool-helps-link-brsk1-variants-to-neurodevelopmental-disorder
Posted inGenetics

AI Tool Helps Link BRSK1 Variants to Neurodevelopmental Disorder

September 28, 2026
For many families affected by rare genetic conditions, genomic testing does not immediately deliver an answer. Now, researchers have combined…
Read More
antibody-blocks-t-cell-infiltration-and-limits-neurodegeneration-in-alzheimer’s-mice
Posted inGenetics

Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice

September 28, 2026
Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to reducing neurodegeneration in…
Read More
ai3bio-emerging-from-stealth-to-‘take-the-gun-out-of-the-hands-of-the-immune-system’
Posted inBiotechnology

ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’

September 28, 2026
ai3Bio has emerged from stealth with $48 million in funding and a buzzing platform for targeting T cells in autoimmune…
Read More
scientists-observe-enzymes-breaking-down-dna-in-real-time
Posted inGenetics

Scientists Observe Enzymes Breaking Down DNA in Real Time

September 28, 2026
The Kanazawa University experiments revealed how the physical organization of DNA can protect it from degradation. [Just_Super/Getty Images] Researchers at…
Read More

Posts pagination

1 2 3 … 2,375 Next page
You May Have Missed
Posted inMedical Technology

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

Posted inMedical Technology

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Posted inMedical Technology

Adagio Medical kicks off strategic review, trims more than half its staff

Posted inMedical Technology

Grail survives adcomm vote as it awaits FDA decision for cancer blood test

Privacy Policy    Terms

Scroll to Top